Luciana Borio, MD retweeted
ARCH’s love is biotech. But we were founded by a physicist, and focus on science. We pioneered expert systems in healthcare (R2), and internet (Netbot). We invest where can revolutionize the broken system. Co-founding Prometheus and Xaira and Insitro, seeding Flourish and TraseAI are reflections of that in AI. We are working on big ideas in biologic data, quantum computing, and DNA computing. Some that will revolutionize healthcare, some that will just revolutionize the way we make things or compute. Never have we been more excited about the pace of innovation, in spite of all the political drama. USA is well positioned to lead the coming waves, if we continue to reward risk takers.
Luciana Borio, MD retweeted
Great to see FDA & the administration prioritizing FIH (First in Human) reform. The current IND process is broken & has shifted FIH trials overseas. Countries like Australia have relied on a more flexible, notification-based pathway for years. Now Congress has to act.
Luciana Borio, MD retweeted
Breakthroughs for patients with U.S. innovation relies on a strong and stable FDA. There’s SO much at stake here.
BIO Statement on the Retirement of Richard Pazdur from US FDA | BIO bio.org/press-release/bio-st…
Luciana Borio, MD retweeted
Mpox isn’t over: A silent epidemic is growing dlvr.it/TN3cP1 #Conditions #InfectiousDisease via @kevinmd
Luciana Borio, MD retweeted
Measles is highly contagious & very serious. A severe case can lead to pneumonia and encephalitis (swelling of the brain), or even death. This doesn't have to happen.
The best way to prevent the spread of measles is to get vaccinated.
Luciana Borio, MD retweeted
Another window into points I made in this op ed yesterday, about Chinese biotech displacing U.S. innovation:
China’s share of clinical trial starts dramatically increased — from 1% to 30% over last decade, and Chinese biotech companies are poised to overtake U.S. counterparts
My op-ed on the large shift of drug discovery moving to China and policy steps the U.S. can take to keep the innovation economy in America. "Five years ago, U.S. drug makers didn’t license any new drugs from China. By 2024, 1/3 came from Chinese biotech"
statnews.com/2025/05/06/how-…
Luciana Borio, MD retweeted
How to stop the shift of drug discovery from the U.S. to China
Via @ScottGottliebMD
statnews.com/2025/05/06/how-…
Luciana Borio, MD retweeted
With ambiguous and scientifically unsupported statements on the Novavax COVID vaccine HHS, FDA have allowed politics to override public health. The consequences won't be limited to vaccines. biocentury.com/article/65577…
Luciana Borio, MD retweeted
Today, @ParadigmHLTH is announcing a dedicated effort to expand clinical trial access in rural America, with former United States Secretary of Veterans Affairs @DavidShulkin joining as an advisor.
paradigm.inc/news/david-shul…
Luciana Borio, MD retweeted
NIH 2025 summer internships cancelled. This really sucks. NIH internships have launched many scientific careers. At a time when the U.S. is discouraging foreign students, how can it make sense to kill a program that costs pennies and is critical to building homegrown scientists?
Luciana Borio, MD retweeted
In my 40 years of biotech, I was waiting to see this result. Never before have transplanted cells survived normal immune response without immunosuppression. Excited for patients, many whom I know see hope today for a possible cure for many diseases. globenewswire.com/news-relea…
Luciana Borio, MD retweeted
"The Biden administration’s bird flu response has been too slow. Now comes a test for Trump’s White House," writes Scott Gottlieb and CFR's @llborio. washingtonpost.com/opinions/…
Luciana Borio, MD retweeted
Really great insights and recs for H5N1 response from @llborio @ScottGottliebMD 👇🏻
Luciana Borio, MD retweeted
If you missed the recent @NTI_WMD seminar w/ @llborio & @JaimeYassif on the H5N1 bird flu outbreak, a recording is now available. "The bottom line is that this virus can totally surprise us, and my fear is that it will continue to do so," said Borio. youtube.com/watch?v=u00wPBIa…
Luciana Borio, MD retweeted
Normally I would be thrilled when a senior official at @US_FDA cites a study of ours, but not this time. As @matthewherper writes in @statnews, @FDACBER Director Dr. Marks justified his unilateral full approval of #Elevidys citing our study misleadingly: statnews.com/2024/07/02/fda-…
Luciana Borio, MD retweeted
How controversial was the decision to approve $SRPT's gene therapy at the FDA?
It goes right down to the footnotes.
Not only did FDA official Peter Marks overrule his staff -- for a key part of his argument, he ended up citing his critics, who found his argument "misleading."
More here:
statnews.com/2024/07/02/fda-…
Luciana Borio, MD retweeted
Not so much "FDA approved " but "Peter approved"
Brilliant @AlecGaffney
Spot on, @AgencyIQ @AlecGaffney on @US_FDA's stunning approval of #Elevidys: - ['FDA approved'] is meant to convey weight & power – that a product has undergone rigorous review by a team of FDA experts & has been found to be safe, effective, & manufactured to quality standards.
Luciana Borio, MD retweeted
The linked article outlines a major step forward in a linked surveillance approach after a slow start. Only 44 symptomatic exposed patients tested as of yesterday but that should increase rapidly now
CDC plans to conduct enhanced, nationwide summer monitoring to help detect even rare human cases of #H5N1 in the community, in addition to raising awareness about H5N1 via targeted outreach to farmworkers in affected communities. More #birdflu updates: bit.ly/3yBu6Us


























